机构:[1]Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, the First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan Road 2, Guangzhou, 510080, People's Republic of China.中山大学附属第一医院[2]Department of Ultrasound Medicine, West China Xiamen Hospital of Sichuan University, Xiamen, China.[3]Department of Medical Ultrasonics, the Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.深圳市康宁医院深圳医学信息中心中国医学科学院阜外医院深圳医院[4]Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.中山大学附属第一医院[5]Department of Medical Ultrasound, the First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang West Road, Guangzhou, 510120, China.
National Nature Science
Foundation of China (NO: 82171960, 82102078, and 81971630),
Guangdong Natural Science Foundation (NO: 2021B1515020054,
2022A1515011148, 2021B1515120030), Guangzhou Science and
Technology Project (NO: 201904010187), and Guangdong Medical
Scientific Research Foundation (NO: A2021344).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|2 区核医学
最新[2023]版:
大类|2 区医学
小类|2 区核医学
第一作者:
第一作者机构:[1]Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, the First Affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan Road 2, Guangzhou, 510080, People's Republic of China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Huang Hui,Li Chao-Qun,He Dan-Ni,et al.Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound[J].European radiology.2023,doi:10.1007/s00330-023-09811-w.
APA:
Huang Hui,Li Chao-Qun,He Dan-Ni,Ruan Si-Min,Li Ming-de...&Chen Li-da.(2023).Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.European radiology,,
MLA:
Huang Hui,et al."Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound".European radiology .(2023)